MedPath

Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity

Recruiting
Conditions
Spinal Cord Injury and Stroke
Registration Number
NL-OMON26235
Lead Sponsor
Sint Maartenskliniek Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

A minimum of 6 months post-lesion/post-stroke to ensure that the subject has a stable neurological condition, without clinical alterations.
- Age 18 years or older at the time of the study
- Spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score = 1
- Have an ankle joint range of motion (ROM) of at least 20°in the sagittal plane
- Ability to make a transfer on to the Achilles (medical device)
- Current treatment of any/all of the m. triceps surae with BoNT-A for spasticity reduction

Exclusion Criteria

- Have a MAS score of 4
- Receive BoNT-A combined with other therapies aimed at reducing spasticity

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reflexive joint resistance (Nm/rad/s)
Secondary Outcome Measures
NameTimeMethod
Intrinsic joint resistance (Nm/rad)
© Copyright 2025. All Rights Reserved by MedPath